14:1 EPC trifluoromethanesulfonate

Cat. No.: HY-144015: Ficha de datos Instrucciones de manejo
FAQs
Technical Support

14:1 EPC trifluoromethanesulfonate is ethyl-phosphatidylcholine (EPC) with monounsaturated 14:1 chains. 14:1 EPC trifluoromethanesulfonate shows transfection activity. 14:1 EPC trifluoromethanesulfonate can be used for drug delivery.

Para uso exclusivo en investigación. No vendemos a pacientes.

14:1 EPC trifluoromethanesulfonate Estructura química

No. CAS : 1246304-44-8

Tamaño	Stock	Cantidad
1 mg	Obtener un presupuesto 3 - 4 Weeks 4 - 5 Weeks 5 - 6 Weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
5 mg	Obtener un presupuesto 3 - 4 Weeks 4 - 5 Weeks 5 - 6 Weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
10 mg	Obtener un presupuesto 3 - 4 Weeks 4 - 5 Weeks 5 - 6 Weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
50 mg	Obtener un presupuesto
100 mg	Obtener un presupuesto

Synthetic products have potential research and development risk.

or Consulta para venta a granel

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Revisión del cliente

Based on 1 publication(s) in Google Scholar

Recomendaciones destacadas

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn	14:1 EPC trifluoromethanesulfonate is ethyl-phosphatidylcholine (EPC) with monounsaturated 14:1 chains. 14:1 EPC trifluoromethanesulfonate shows transfection activity. 14:1 EPC trifluoromethanesulfonate can be used for drug delivery^[1]^[2].
Peso molecular	852.03
Fòrmula	C₃₉H₇₃F₃NO₁₁PS
No. CAS	1246304-44-8
SMILES	O=S(C(F)(F)F)([O-])=O.C[N+](C)(C)CCOP(OC[C@@H](COC(CCCCCCC/C=C\CCCC)=O)OC(CCCCCCC/C=C\CCCC)=O)(OCC)=O
Envío	Room temperature in continental US; may vary elsewhere.
Almacenamiento	Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación	Ficha de datos (261 KB) Instrucciones de manejo (2659 KB)
Referencias	[1]. Koynova R, et al. Enhancing nucleic acid delivery, insights from the cationic phospholipid carriers. Curr Pharm Biotechnol. 2014;15(9):806-13. [Content Brief] [2]. Koynova R, et al. Hydrophobic moiety of cationic lipids strongly modulates their transfection activity. Mol Pharm. 2009 May-Jun;6(3):951-8. [Content Brief]